Compartir
Título
Current Trends in SPR Biosensing of SARS-CoV-2 Entry Inhibitors
Autor
Facultad/Centro
Área de conocimiento
Título de la revista
Chemosensors
Número de la revista
12
Cita Bibliográfica
Mauriz E, Lechuga LM. Current Trends in SPR Biosensing of SARS-CoV-2 Entry Inhibitors. Chemosensors. 2021; 9(12):330. https://doi.org/10.3390/chemosensors9120330
Editorial
MDPI
Fecha
2021
Resumen
The emerging risk of viral diseases has triggered the search for preventive and therapeutic agents. Since the beginning of the COVID-19 pandemic, greater efforts have been devoted to investigating virus entry mechanisms into host cells. The feasibility of plasmonic sensing technologies for screening interactions of small molecules in real time, while providing the pharmacokinetic drug profiling of potential antiviral compounds, offers an advantageous approach over other biophysical methods. This review summarizes recent advancements in the drug discovery process of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) inhibitors using Surface Plasmon Resonance (SPR) biosensors. A variety of SPR assay formats are discussed according to the binding kinetics and drug efficacies of both natural products and repurposed drugs. Special attention has been given to the targeting of antiviral agents that block the receptor binding domain of the spike protein (RBD-S) and the main protease (3CLpro) of SARS-CoV-2. The functionality of plasmonic biosensors for high-throughput screening of entry virus inhibitors was also reviewed taking into account experimental parameters (binding affinities, selectivity, stability), potential limitations and future applications.
Materia
Palabras clave
Peer review
SI
URI
DOI
Aparece en las colecciones
- Artículos [5045]
Ficheros en el ítem
Tamaño:
4.396
xmlui.dri2xhtml.METS-1.0.size-megabytes
Formato:
Adobe PDF